Drug Discovery Services Market Size, Growth Drivers and Future Outlook
市场洞察和分析师观点：
药物发现是识别或开发新药物来治疗疾病和改善人类健康的过程。它涉及从合成到实验室和动物模型测试以及人体试验评估等各个阶段识别潜在候选药物。药物发现服务提供商提供专业知识和资源来支持药物发现过程。这可以包括药物化学、计算建模、高通量筛选和临床前测试服务。这些服务通常由合同研究组织 (CRO) 或学术研究机构提供。制药公司和生物技术公司选择这些服务来加速药物发现过程，而不影响其效率。
增长驱动因素和挑战：
由于各个领域对新疗法的需求不断增加，药物发现服务市场正在经历显着增长。一系列治疗领域。药物发现过程复杂且耗时，其成功取决于对潜在候选药物进行的广泛研究及其测试和验证。因此，制药公司和研究机构越来越依赖药物发现服务提供商来支持他们的药物开发工作。这些服务提供商提供靶标识别和验证、先导化合物优化、临床前研究、药代动力学和毒理学测试以及其他值得注意的服务。生物技术和制药公司正在寻求开发有针对性的治疗方法，以解决个体患者的特定遗传和分子特征，从而实现更加个性化的医疗保健方法。对精准医疗和个性化治疗的日益关注进一步推动了对药物发现服务的需求。
制药公司不断增加研发投资，以及高通量筛选、计算建模和人工智能等先进技术的可用性进一步提高有利于药物发现服务市场。这些技术使药物发现过程更加高效和有效，从而提高新药推向市场的成功率。发现和开发新药的过程成本高昂，通常需要在研究、开发和临床试验方面进行大量投资。去年，基因工程与生物技术研究中审查的全球前 20 名生物制药中，创造新药的平均成本增加了 15%（2.98 亿美元），达到近 23 亿美元。
后期候选药物的失败率很高临床研究的数量进一步增加了药物开发的总体成本。因此，制药和生物技术公司越来越多地寻求具有成本效益的药物发现服务，这迫使服务提供商提供有竞争力的价格，同时保持高质量标准。药物分子的高成本也影响了患者对新疗法的承受能力，特别是在罕见疾病或利基治疗领域，这是药物开发商和医疗保健系统在提供创新药物的过程中面临的主要挑战领域治疗。
报告细分和范围：
药物发现服务市场根据流程、类型、分子类型、治疗领域和最终用户进行细分。根据流程，市场分为目标选择和验证、先导化合物识别和其他（分析开发、筛选等）。药物发现服务市场按类型分为生物学服务、药物化学药物代谢和药代动力学。从分子类型来看，药物发现服务市场分为生物制剂和小分子。根据治疗领域，市场分为心血管疾病、肿瘤、神经病学、糖尿病、呼吸系统疾病等。按最终用户划分，药物发现服务市场分为制药和生物技术公司、学术机构等。根据地理位置，药物发现服务市场分为北美（美国、加拿大和墨西哥）、欧洲（英国、德国、法国、意大利、西班牙和欧洲其他地区）、亚太地区（中国、日本、印度、韩国、澳大利亚和亚太其他地区）、中东和非洲（阿联酋、沙特阿拉伯、南非以及中东和非洲其他地区）以及南美洲和中美洲（巴西、阿根廷以及中南部和中部其他地区）美国）。
细分市场分析：
根据分子类型，小分子细分市场在药物发现服务市场中占有较大的收入份额。小分子市场的增长归因于它们易于研究、定义明确且易于表征。
药物发现服务市场，按分子类型 – 2022 年和 2030 年
2022 年，按类型划分，化学领域在药物发现服务市场中占有最大份额。药物化学在药物发现的各个领域都有广泛的用途，从候选药物的交付到临床前研究。
就治疗领域而言，肿瘤学领域在 2022 年的药物发现服务市场中占据主导地位。该领域的市场增长归因于全球癌症相关药物发现工作的增加。由于普通人群中各种癌症的发病率不断上升，肿瘤学是一个不断增长的市场。国际癌症研究机构估计，2020 年将有约 1000 万癌症相关死亡和 1930 万新癌症病例。预计 2020 年至 2040 年，全球新癌症病例数将增加 47%。因此，近 2840 万癌症病例预计到 2040 年，全球将出现新的癌症病例。
区域分析：
根据地理位置，药物发现服务市场主要分为北美、欧洲、亚太地区、中东和非洲以及南美洲和中美洲。北美是全球市场增长的最重要贡献者。该地区的市场增长归因于药物开发公司的投资、美国政府提供的大量资助、主要药物开发公司的强劲存在、完善的医疗基础设施以及慢性病发病率的增加。
美国癌症协会的“2022 年癌症事实与数据”估计，到 2022 年底，美国将有约 1,918,030 例新癌症病例和 609,360 例与癌症相关的死亡。鉴于该领域的高癌症发病率，创新癌症药物的研究活动可能会发生未来几年将在美国蓬勃发展。 CytoReason 与辉瑞于 2022 年 9 月签署了多年合作协议。根据这项协议，辉瑞可以使用 CytoReason 的人工智能技术进行药物开发。美国大公司在药物发现中使用人工智能技术预计将推动药物发现服务市场的扩张。
预计 2022 年至 2030 年，亚太地区的药物发现服务市场复合年增长率最高。该地区的市场增长归因于中国、印度、日本和韩国等国家不断增加的研发活动投资，这些国家正在成为重要的制药和生物技术中心。此外，亚太地区拥有大量熟练的研究人员和科学家，以及与西方国家相比较低的运营成本，使亚太地区成为外包药物发现服务的有吸引力的目的地。慢性病的患病率不断上升，以及对创新药物来解决未满足的医疗需求的需求正在创造对新药物的需求，从而有利于该地区药物发现服务市场的增长。
竞争格局和主要公司：
安捷伦科技Ubiquigent、Abbott Laboratories Inc.、Advinus Therapeutics Albany Molecular Research Inc.、Aurigene、Bayer AG、AstraZeneca PLC、Charles River Laboratories International、Covance 和 ChemBridge Corporation 是药物发现服务市场上的一些知名参与者。这些公司专注于扩大服务范围，以满足全球不断增长的消费者需求。他们的全球业务使他们能够为大量客户提供服务，从而扩大他们的市场份额。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Increasing demand for novel therapies across a wide range of therapeutic areas, and rising R&D expenditure in the pharmaceutical and biotechnology industries are driving the drug discovery services market. However, the high cost of drug discoveries hinders the drug discovery services market growth.
The drug discovery services market was valued at US$ 19,539.00 million in 2022.
Drug discovery is the process of identifying and characterizing molecules with the potential to safely modulate disease, with a goal to bring medicines that can improve the lives of patients. It is a lengthy and resource intensive process, that requires close cooperation across multiple disciplines.
The drug discovery services market has major market players, including Abbott Laboratories Inc., Agilent Technologies Ubiquigent, Albany Molecular Research Inc., Advinus Therapeutics, AstraZeneca PLC, Bayer AG, Aurigene, Charles River Laboratories International, ChemBridge Corporation, and Covance.
The drug discovery services market is expected to be valued at US$ 56,783.29 million in 2030.
Based on molecule type, the small molecules segment held the most revenue share in the worldwide drug discovery services market. Its rise was encouraged by the tiny molecules' simple, well-defined, and easy-to-characterized nature. The public is more in demand for and considerably more productive with small molecule pharmaceuticals. Because they are small molecules, they small molecules can affect cells readily and can be used to treat patients effectively. This market has grown as a result of a growing understanding of the advantages of small-molecule medications.
In 2022, the medicinal chemistry segment held the largest market share in the drug discovery services market based on type. Medicinal chemistry finds extensive use in drug discovery services, ranging from candidate delivery to preclinical studies. Consequently, this segment's prominence can be attributed to its significance. Furthermore, the biopharmaceutical businesses' increased outsourcing is anticipated to fuel this segment's expansion.
In 2022, on the basis of therapeutic area, the global market for drug discovery services was dominated by the oncology segment, owing to increase in cancer-related medication discovery efforts. The oncology market has grown as a result of the rising incidence of various cancers in the general population. The International Agency for Research on Cancer estimates that there will be about 10 million cancer-related deaths and 19.3 million new cancer cases in 2020. The global number of new cancer cases is predicted to increase by 47% between 2020 and 2040. As a result, it is projected that there will be about 28.4 million new instances of cancer worldwide in 2040.
The List of Companies - Drug Discovery Services Market
- Agilent Technologies Ubiquigent
- Abbott Laboratories Inc.
- Advinus Therapeutics Albany Molecular Research Inc.
- Aurigene
- Bayer AG
- AstraZeneca PLC
- Charles River Laboratories International
- Covance
- ChemBridge Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For